These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Khazanie P, Greiner MA, Al-Khatib SM, Piccini JP, Turakhia MP, Varosy PD, Masoudi FA, Curtis LH, Hernandez AF, National Cardiovascular Data Registry. Circ Heart Fail; 2016 Jun 07; 9(6):. PubMed ID: 27296396 [Abstract] [Full Text] [Related]
5. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention. Khazanie P, Hellkamp AS, Fonarow GC, Bhatt DL, Masoudi FA, Anstrom KJ, Heidenreich PA, Yancy CW, Curtis LH, Hernandez AF, Peterson ED, Al-Khatib SM. J Am Heart Assoc; 2015 Aug 06; 4(8):e002061. PubMed ID: 26251283 [Abstract] [Full Text] [Related]
6. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Bansal N, Szpiro A, Masoudi F, Greenlee RT, Smith DH, Magid DJ, Gurwitz JH, Reynolds K, Tabada GH, Sung SH, Dighe A, Cassidy-Bushrow A, Garcia-Montilla R, Hammill S, Hayes J, Kadish A, Sharma P, Varosy P, Vidaillet H, Go AS. Heart; 2017 Apr 06; 103(7):529-537. PubMed ID: 27742796 [Abstract] [Full Text] [Related]
7. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death. Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ. Circ Arrhythm Electrophysiol; 2016 Mar 06; 9(3):e003283. PubMed ID: 26921377 [Abstract] [Full Text] [Related]
8. Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Heart Failure Patients With Diabetes Mellitus. Sharma A, Wu J, Xu H, Hernandez A, Felker GM, Al-Khatib S, Green J, Matsouaka R, Fonarow GC, Singh JP, Heidenreich PA, Ezekowitz JA, DeVore A. J Am Heart Assoc; 2020 Jun 16; 9(12):e012405. PubMed ID: 32476539 [Abstract] [Full Text] [Related]
12. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease. Bansal N, Szpiro A, Reynolds K, Smith DH, Magid DJ, Gurwitz JH, Masoudi F, Greenlee RT, Tabada GH, Sung SH, Dighe A, Go AS. JAMA Intern Med; 2018 Mar 01; 178(3):390-398. PubMed ID: 29404570 [Abstract] [Full Text] [Related]
13. Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women. Zeitler EP, Hellkamp AS, Schulte PJ, Fonarow GC, Hernandez AF, Peterson ED, Sanders GD, Yancy CW, Al-Khatib SM. Circ Heart Fail; 2016 Jan 01; 9(1):e002630. PubMed ID: 26758365 [Abstract] [Full Text] [Related]
14. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation. Fröhlich GM, Holzmeister J, Hübler M, Hübler S, Wolfrum M, Enseleit F, Seifert B, Hürlimann D, Lehmkuhl HB, Noll G, Steffel J, Falk V, Lüscher TF, Hetzer R, Ruschitzka F. Heart; 2013 Aug 01; 99(16):1158-65. PubMed ID: 23813845 [Abstract] [Full Text] [Related]
15. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator. Martens P, Verbrugge FH, Nijst P, Dupont M, Nuyens D, Herendael HV, Rivero-Ayerza M, Tang WH, Mullens W. Heart; 2017 Dec 01; 103(24):1977-1984. PubMed ID: 28716973 [Abstract] [Full Text] [Related]
17. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry. Amit G, Suleiman M, Konstantino Y, Luria D, Kazatsker M, Chetboun I, Haim M, Gavrielov-Yusim N, Goldenberg I, Glikson M, Israeli Working Group on Pacing and Electrophysiology. Europace; 2014 Aug 01; 16(8):1175-80. PubMed ID: 24554524 [Abstract] [Full Text] [Related]
18. Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry. Schrage B, Uijl A, Benson L, Westermann D, Ståhlberg M, Stolfo D, Dahlström U, Linde C, Braunschweig F, Savarese G. Circulation; 2019 Nov 05; 140(19):1530-1539. PubMed ID: 31476893 [Abstract] [Full Text] [Related]
19. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation. Cantero-Pérez EM, Sobrino-Márquez JM, Grande-Trillo A, Lage-Gallé E, Rangel-Sousa D, Esteve-Ruiz IM, Martínez-Martínez A. Transplant Proc; 2013 Nov 05; 45(10):3659-61. PubMed ID: 24314988 [Abstract] [Full Text] [Related]